IQVIA Holdings' Q4 Beats Street View, Lifts FY22 Earnings Guidance

IQVIA Holdings Inc IQV has posted Q4 adjusted EPS of $2.55, up 20.9% Y/Y, surpassing the consensus of $2.43.

  • Revenue of $3.64 billion increased 10.2% on a reported basis and 11.6% at constant currency, ahead of the consensus of $3.59 billion.
  • Technology & Analytics Solutions' revenue of $1.49 billion grew 5% on a reported basis and 6.6% at constant currency. 
  • Research & Development Solutions (R&DS) revenue increased 15.4% on a reported basis and 16.3% at constant currency to $1.94 billion. 
  • R&D Solutions contracted backlog of $24.8 billion grew 10.2% Y/Y.
  • Adjusted EBITDA increased 12.7% to $828 million.
  • Share Buyback: In February, the IQVIA board approved an increase of the share repurchase authorization by $2.0 billion, bringing the remaining authorization to just over $2.5 billion.
  • Outlook: For FY22, IQVIA is reaffirming the revenue guidance of $14.7 billion - $15 billion (consensus of $14.97 billion), despite a $70 million revenue headwind from changes in foreign currency exchange rates. 
  • The company is raising the Adjusted EBITDA outlook to $3.33 billion - $3.41 billion, and Adjusted EPS guidance to $9.95 - $10.25 (consensus of $10.14).
  • For Q1, the company expects revenue of $3.515 billion - $3.575 billion (consensus $3.63 billion). It sees Q1 Adjusted EPS of $2.40 - $2.46, against the consensus of $2.44.
  • Price Action: IQV shares closed lower by 1.79% at $239.90 on Monday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceHealth CareBuybacksGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!